1. United States
2. Calif.
3. Letter

The proposed legislation raises significant concerns about the potential risks of allowing artificial intelligence (AI) and machine learning technologies to prescribe drugs without proper oversight and safeguards. While technological advancements can improve healthcare delivery, the implications of such a move require careful consideration. AI systems lack the nuanced understanding and ethical reasoning that human medical professionals possess, which could lead to serious consequences if given prescriptive authority without stringent regulation. Prescription drugs carry inherent risks, and their misuse or improper administration can have severe adverse effects on patients' health and well-being. Entrusting this critical responsibility solely to AI systems raises alarming questions about accountability, transparency, and the potential for errors or biases to creep into the decision-making process. It is crucial to prioritize patient safety and uphold the highest standards of care. Before granting prescriptive powers to AI, a thorough evaluation of the technology's capabilities, limitations, and potential impact on public health must be conducted. Patient-provider relationships built on trust and human empathy should remain at the core of healthcare delivery. Responsible innovation demands a cautious and meticulous approach to integrating AI into medical practices while maintaining robust human oversight and ethical guidelines.